Josh Fairbank
CEO, Chairman, Founder @ Base4 Biotechnology
Chicago, United States
Josh Fairbank is a startup investor at Base4 Biotechnology in Chicago. Joshua is a founder of Base4 and has sat at the intersection of entrepreneurship and investments for two decades. Prior to Base4, he co-founded and took public Akebia (NASDAQ: AKBA), a biotech in kidney disease and Aerpio (NASDAQ: ARPO), a biotech in ocular diseases. He was also the Founding Partner of Orchard Venture Partners (a biotech VC fund)and of Orchard Capital Management. Fairbank is also an Adjunct Professor of Entrepreneurship at the University of Chicago Booth School of business. He received his MBA from Chicago Booth and his BA in Economics from Connecticut College.
Last updated:
For AI agents: llms.txt
About Base4 Biotechnology
Nymirum is a venture-backed, privately held company that has developed the RNArchitect suite to rapidly solve high-resolution RNA 3D structures and a proprietary drug discovery platform that targets RNA with small molecules.
Base4 Biotechnology Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Josh Fairbank
CEO, Chairman, Founder
|
|||
Michael E. Pape
Board of Directors
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
